NCT04209660 2025-10-07Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland CancersMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting64 enrolled